Discovery of a new potential treatment for visceral leishmaniasis


(University of Dundee) A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world's major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and Wellcome.Visceral leishmaniasis is a disease which kills tens of thousands of people every year, mainly among the poorest in the world.

Leave A Reply

Your email address will not be published.